abstract |
The present invention relates to HSP90 inhibitors that are useful as inhibitors of HSP90 comprising a fused aminopyridine core and their use in the treatment of HSP90 related diseases and disorders such as cancer, autoimmune diseases or neurodegenerative diseases. |